v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
REVENUES:        
Total revenues $ 20,680,550 $ 10,276,358 $ 54,559,758 $ 28,263,696
OPERATING EXPENSES:        
Cost of product revenue (exclusive of amortization expense shown below) 20,295,213 11,855,464 56,897,959 42,180,319
Research and development 770,557 1,708,391 2,917,072 4,893,549
Plasma center operating expenses 3,146,221 1,218,898 8,191,890 2,597,444
Amortization of intangible assets 178,838 178,838 536,514 536,514
Selling, general and administrative 10,726,797 9,115,744 31,198,880 25,750,458
Total operating expenses 35,117,626 24,077,335 99,742,315 75,958,284
LOSS FROM OPERATIONS (14,437,076) (13,800,977) (45,182,557) (47,694,588)
OTHER INCOME (EXPENSE):        
Interest income 4,256 1,164 32,241 268,643
Interest expense (3,298,680) (3,091,200) (9,741,110) (8,875,597)
Other income (expense) 18,546 (26,440) (106,772) (39,232)
Other expense, net (3,275,878) (3,116,476) (9,815,641) (8,646,186)
NET LOSS $ (17,712,954) $ (16,917,453) $ (54,998,198) $ (56,340,774)
BASIC LOSS PER COMMON SHARE (in dollars per share) $ (0.13) $ (0.19) $ (0.44) $ (0.68)
DILUTED LOSS PER COMMON SHARE (in dollars per share) $ (0.13) $ (0.19) $ (0.44) $ (0.68)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic (in shares) 133,770,147 87,698,258 125,682,400 82,627,753
Diluted (in shares) 133,770,147 87,698,258 125,682,400 82,627,753
Product Revenue [Member]        
REVENUES:        
Total revenues $ 20,644,842 $ 10,240,650 $ 54,452,633 $ 28,156,571
License Revenue [Member]        
REVENUES:        
Total revenues $ 35,708 $ 35,708 $ 107,125 $ 107,125

Source